ÂÜÀòÂÒÂ×

Ed Roschak has held various leadership positions in the medical device industry since 2000. Ed started at Broncus Technologies in 2000 as Senior Vice President of Research and Development. In 2010, they joined Ellipse Technologies, Inc. as President, CEO, Director and Chief Operating Officer. In 2016, they became the CEO of NuVasive Specialized Orthopedics. In 2017, they were the Chairman of ApiFix, which was acquired by Orthopediatrics. Ed then became President, CEO, and Director of Vascular Dynamics in 2017, and Director of Perfuze in 2019.

Ed Roschak received their MBA from the University of Oregon in 1999 and their BSME from UC Santa Barbara in 1989.